Medicines for Malaria Venture

Medicines for Malaria Venture reduces the malaria burden in malaria-endemic countries by discovering, developing, and facilitating the delivery of new, effective, and affordable antimalarial drugs. Since its establishment in 1999, MMV and its partners have developed and launched fourteen new drugs, two of which were added to the portfolio after approval.